제2형 당뇨병 환자에서 혈당강하제와 보중익기탕 병용 투여가 혈당 변화에 미치는 영향 및 안전성 연구
A Retrospective Study of the Safety and Effect of Co-administration of Glucose-lowering Medication and Bojungikgi-tang on Blood Glucose Level in Patients with Type 2 Diabetes Mellitus
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: This study aimed to assess the safety and effect on glucose level of Bojungikgi-tang in patients with type 2 diabetes mellitus. Methods: To review patients’ clinical characteristics and laboratory tests retrospectively, we investigated 15 hospitalized patients with type 2 diabetes mellitus who took Bojungikgi-tang at Kyung Hee University Korean Medical Hospital for at least one day between January 2012 and December 2022. The blood glucose levels, including fasting blood sugar (FBS), 2-hour postprandial glucose (PP2) levels, and glycated hemoglobin level, were collected to determine the effect of the Bojungikgi-tang on blood sugar changes. Furthermore, to evaluate the safety of Bojungikgi-tang, hepatic function and renal function tests were implemented, including aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, γ-glutamyltransferase, blood urea nitrogen, creatinine, and Modification of Diet in Renal Disease estimated glomerular filtration rate. Results: When Bojungikgi-tang and a standard treatment for diabetes were administered for patients with type 2 diabetes, it was confirmed that there were no statistically significant changes in FBS and PP2 levels in the analysis of each medication taken. There was no significant difference in the safety profile after taking Bojungikgi-tang. Conclusions: The combined administration of Bojungikgi-tang with standard hypoglycemic medication for patients with type 2 diabetes may not affect blood glucose levels and safety.
Abstract
Objective: This study aimed to assess the safety and effect on glucose level of Bojungikgi-tang in patients with type 2 diabetes mellitus. Methods: To review patients’ clinical characteristics and laboratory tests retrospectively, we investigated 15 hospitalized patients with type 2 diabetes mellitus who took Bojungikgi-tang at Kyung Hee University Korean Medical Hospital for at least one day between January 2012 and December 2022. The blood glucose levels, including fasting blood sugar (FBS), 2-hour postprandial glucose (PP2) levels, and glycated hemoglobin level, were collected to determine the effect of the Bojungikgi-tang on blood sugar changes. Furthermore, to evaluate the safety of Bojungikgi-tang, hepatic function and renal function tests were implemented, including aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, γ-glutamyltransferase, blood urea nitrogen, creatinine, and Modification of Diet in Renal Disease estimated glomerular filtration rate. Results: When Bojungikgi-tang and a standard treatment for diabetes were administered for patients with type 2 diabetes, it was confirmed that there were no statistically significant changes in FBS and PP2 levels in the analysis of each medication taken. There was no significant difference in the safety profile after taking Bojungikgi-tang. Conclusions: The combined administration of Bojungikgi-tang with standard hypoglycemic medication for patients with type 2 diabetes may not affect blood glucose levels and safety.
참고문헌 (20)
- Korean diabetes association, "Diabetes fact sheet in Korea 2022", ~ (2022)
- 대한내분비학회, "내분비대사학", pp.896~897 (2022), 군자출판사
- Diabetes guideline committee, "Treatment guideline for diabetes 2021", Korean diabetes association, 37~ (2021)
- 유창환, "한약 복용이 제 2형 당뇨 환자의 혈당 변화에 미치는 영향 : 후항적 차트 리뷰", 대한한방내과학회지, 41(6), pp.1066~1077 (2020), 대한한방내과학회[DOI]
- 오승현, "표준 치료를 받고 있는 제2형 당뇨병 환자에 대한 구미강활탕, 평위산, 반하사심탕 복용이 혈당에 미치는 영향 및 안전성 연구", 대한한방내과학회지, 43(3), pp.363~374 (2022), 대한한방내과학회[DOI]
- 이민승, "오적산 병용투여가 혈당강하 치료를 받고 있는 제2형 당뇨병 환자의 혈당에 미치는 영향", 대한한방내과학회지, 42(1), pp.40~52 (2021), 대한한방내과학회[DOI]
- 2021급여의약품 청구현황, "건강보험심사평가원", 건강보험심사평가원, 76~78 (2022)
- "의약품안전나라"[URL]
- Huang P, "Effect of modified Buzhong Yiqi decoction on blood glucose level in diabetic patients", Clinical medical & engineering, 22(5), pp.596~597 (2015)
- Kim JM, "Management of hyperglycemia in type 2 diabetes : a summary of new consensus report from the American Diabetes Association and the European Association for the study of diabetes in 2018", J Korean Diabetes, 20(1), pp.6~9 (2019)
- Hur KY, "2021 Clinical practice guidelines for diabetes : pharmacotherapy and the Korean diabetes association support system", J Korean diabetes, 22(4), pp.250~258 (2021)
- 문수정, "지역사회 기반 당뇨병 환자의 보완대체요법 이용 실태조사", 대한한방내과학회지, 33(3), pp.317~326 (2012), 대한한방내과학회
- 이연경, "당뇨병 및 消渴의 최신 연구 동향 -2003년에서 2007년까지 한의학술논문을 중심으로-", 대한한의학 방제학회지, 15(2), pp.21~33 (2007), 대한한의학방제학회
- 김도형, "당뇨병의 한의학적 치료에 대한 최신 연구 동향 - 2008년부터 2013년까지 국내 학술논문을 중심으로 -", 대한한방내과학회지, 34(3), pp.240~255 (2013), 대한한방내과학회
- 손아현, "당뇨병의 한의학적 치료에 대한 국내 실험연구 고찰 - 2013년 이후", 대한한방내과학회지, 38(1), pp.10~19 (2017), 대한한방내과학회
- 최혜민, "보중익기탕 (補中益氣湯)의 한국, 중국, 일본 처방에 대한 항염증 및 항산화 효과 비교 연구", 대한본초학회지, 29(1), pp.53~60 (2014), 대한본초학회
- 范军, "补中益气汤加味治疗糖尿病肾病100例", 陕西中医, 32(8), pp.960~962 (2011)
- 강윤미, "보중익기탕(補中益氣湯)이 streptozotocin 유발 당뇨병성 위부전마비백서에 미치는 영향", 대한본초학회지, 34(6), pp.45~55 (2019), 대한본초학회[DOI]
- Park SD, "Effects of Bojungikgitang, Soeumin bojungikgitang and its component groups on diabetes in alloxan induced diabetic rats", Herbal Formula Science, 9(1), pp.215~230 (2001)
- 정수민, "제2형 당뇨병 환자에게 한방의료보험용 혼합엑기스산제와 경구혈당강하제 병용요법이 혈당 변화에 미치는 영향", 대한한방내과학회지, 41(6), pp.1231~1244 (2020), 대한한방내과학회[DOI]